Delivery Order SPE2DB22D2007-SPE2DB25FH8UD

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,478.69, is for the supply of a specific pharmaceutical product, the BREYNA 80-4.5 MCG INHALER 10.3GM. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,951.88 firm fixed-price contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a prescription pharmaceutical product, with a completion date of April 22, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of a pharmaceutical product, specifically the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a firm fixed price of $2,925.48 and a completion date of September 25, 2024. The contract is not set aside for a specific business category. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen leverages its extensive supply chain to provide...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $3,427.22, is for the provision of a pharmaceutical product, specifically a "BREYNA 160-4.5 MCG INHALER 10.3GM." This delivery order was issued under a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract has a ceiling value of $2,535.26 and is for the delivery of the pharmaceutical product "BREYNA 160-4.5 MCG INHALER 10.3GM." The contract does not have a set-aside designation and is scheduled to be completed by April 1, 2024....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $12,621.78 firm-fixed-price contract is for the supply of a pharmaceutical product, specifically a 160-4.5 MCG BREYNA 10.3GM inhaler. The award has an ultimate completion date of August 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various government agencies, including the military, through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,721.19 firm fixed-price delivery order is for the BREYNA 160-4.5 MCG INHALER 10.3GM medical product, with a completion date of January 30, 2025. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,966,027 units of the BREYNA 160-4.5 MCG INHALER 10.3GM pharmaceutical product. The contract has a ceiling value of $4,405.77 and was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 21, 2024 with a completion date of June 24, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,693.99, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract has a completion date of January 22, 2025 and is a Firm Fixed Price contract. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery...
This contract award, with ID SPE2DB20D2104|SPE2DB24FS82H, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.10 firm fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product. The contract has an ultimate completion date of March 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8UD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567152308 BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a ceiling value of $11,669.44. The contract is a firm fixed price delivery order, with an ultimate completion date of February 5, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/6/25, 12:00 PM